申请人:Merck Sharp & Dohme Corp.
公开号:US08017605B2
公开(公告)日:2011-09-13
Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof:
are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
化学式为(I)或其药学上可接受的盐所描述的化合物:是p38抑制剂,可用于治疗炎症,例如哮喘,COPD,ARDS,类风湿性关节炎,类风湿性脊柱炎,骨关节炎,痛风性关节炎和其他关节炎症状;炎症性关节,湿疹,牛皮癣或其他炎症性皮肤病,例如晒伤;包括结膜炎在内的炎症性眼病;与炎症相关的发热,疼痛和其他症状。